Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASR polymorphisms and cinacalcet response in Thai patients
TCTR20190820002Enrolling by invitation
- Sponsor
- Chulalongkorn University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Chulalongkorn University. Primary endpoint: Parathyroid hormone level. Started Aug 2019; status: enrolling by invitation.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on TCTR20190820002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190820002.